. This disease is characterized by hyperabsorption of dietary iron, which leads to progressive iron overload with increases in transferrin saturation and serum ferritin concentrations, F o r P e e r R e v i e w and excess iron deposition in parenchymal cells of the liver, pancreas and heart liable to result in organ damage [Bothwell, 1995; Powell et al., 1999; Niederau et al., 1999] . The clinical onset usually appears after midlife, and the clinical outcomes and severity of the disease varies considerably. Prognosis depends on both an early diagnosis and iterative phlebotomies throughout life to prevent the occurrence of irreversible organ damage caused by iron overload [Adams et al., 1991; Niederau et al., 1996] .
The HFE gene, located on the short arm of human chromosome 6, consists of 6 exons that encode a histocompatibility class I-like protein that associates with β2-microglobulin for normal processing and cell surface expression [Feder et al., 1996] . The HFE protein is predominantly expressed in tissues involved in iron storage, such as hepatocytes and macrophages [Holmström et al., 2003; Zhang et al., 2003] , and its expression is transcriptionally regulated by hepatic C/EBPα and erythroid GATA-1 Makui et al., 2005] . Functional HFE competes with holo-transferrin (holo-Tf) for binding to TfRC (OMIM 190010) , and it interacts with TfR2 (OMIM 604720) independently of holo-Tf Feder et al., 1998; Lebron et al., 1998; Gross et al., 1998; Chen et al., 2007] . Patients affected with HFE-linked hemochromatosis, TfR2-linked hemochromatosis, and Hfe -/-mice, have inappropriately-low expression of the hepcidin peptide which regulates the ferroportin transmembrane iron exporter by inducing its internalization and degradation; both HFE and TfR2 are involved in a HAMP (OMIM 606464) regulatory pathway [Pigeon et al., 2001; Nicolas et al., 2002; Nemeth et al., 2004; Bridle et al., 2003; Nemeth et al., 2005; Wallace et al., 2009] .
Most individuals affected by hemochromatosis (80-90%) are homozygous for the c.845G>A (p.C282Y) substitution. The prevalence of hemochromatosis correlates with the distribution of c.845A throughout the world, and linkage-disequilibrium studies have provided evidence of a founder effect consistent with a single ancestral occurrence of the c.845G>A mutation [Feder et al., 1996; Jazwinska et al., 1996; Carella et al., 1997; Mura et al., 1997] . The p.C282Y mutation disrupts a critical disulfide bond in the α3 domain, which impairs both its association with β2-microglobulin and its normal protein processing Waheed et al., 1997] . However, variable expression of the disease and incomplete penetrance of the c.845A/c.845A genotype (asymptomatic homozygotes have been evaluated to 17.6%), both indicative of modulation of the severity of iron overload by secondary factors, have been observed in population screenings [Rhodes et al., 1997; Crawford et al., 1998; Mura et al., 2001; Beutler et al., 2002] . Non-c.845A patient chromosomes are characterized by a high prevalence of the c.187C>G (p.H63D) variant (40-70% vs. 14%-20% in non-c.845A patient and control chromosomes, respectively), and the c.193A>T (p.S65C) variant (7.2 and 2.49% in patient and control chromosomes with neither c.845G>A or c.187C>G variations) [Feder et al., 1996; Rish 1997; Beutler 1997; Bacon et al., 1999; Moirand et al., 1999; Mura et al., 1999] . Population studies have provided evidence for the very low penetrance of c.187G/c.187G, c.845A/c187G, and c.845A/c.193T or c187G/c.193T genotypes and their association with a milder form of iron overload compared to patients with the c.845A/c.845A genotype. A study of linkage disequilibrium by using external HFE microsatellites showed a similar pattern of haplotypes from c.187G chromosomes in patients and controls, and supports the occurrence of the c.187G variant on a single progenitor haplotype [Feder et al., 1996] . Aside from these variants, few HFE private nonsense and missense mutations in a compound heterozygous state with the c.845A mutation have been correlated with the hemochromatosis phenotype. In a few cases, hemochromatosis has been also correlated with mutations in the coding regions of other genes involved in iron homeostasis such as TfR2, ferroportin, hemojuvelin and hepcidin [Camaschella et al., 2000; Njajou et al., 2001; Papanikolaou et al. 2004] , and digenic inheritance of HFE and one of the other mutated gene was also described [Merryweather-Clarke et al., 2003; Jacolot et al., 2004] .
In the present study, we extended the analysis of HFE by using internal HFE SNPs, and derived haplotypes to determine whether particular alleles are associated with iron overload trait characterized by elevated serum iron parameters. Among non-mutant chromosomes, we discovered a protective haplotype and an at-risk haplotype with two of the five SNPs associated with elevated serum iron parameters; the latter being also in linkage disequilibrium with a subset of c.187G chromosomes. Functional studies of the putative pathogenic HFE SNPs showed that binding by the HIF-1α transcription factor was affected by the g.4694G allele, which is located within the promoter region, and that IVS4 splicing was modified by the c.1007-47A allele.
PATIENTS AND METHODS

Subjects
The present study dealt with 265 unrelated patients with iron overload trait, and 55 healthy-unrelated controls, all from Brittany (France). All patients presented at least two elevated serum iron parameters (transferrin saturation above 60% in males and 50% in females, serum ferritin concentration above 400 µg/L in males and 300 µg/L in females, serum iron concentration above 20 µM) [Mura et al., 1999] , and all patients enrolled in the study were F o r P e e r R e v i e w <Running Title> 3 treated by venesections. Control samples were obtained from healthy blood donors without abnormalities of serum iron indices and without a clinical history of iron metabolism disorder. This study complied with French bioethics regulations. Informed consent of patients was obtained before blood samples were taken.
Reference sequences, nomenclature and primer sequences
Entrez nucleotide database (http//ncbi.nlm.nih.gov) NG_008720.1:g, NM_000410.3:c, NP_000401.1 and dbSNP ID were used as the reference sequences for HFE genomic, cDNA, and protein sequences. DNA sequence variations are named according to the nomenclature recommendations from http://www.hgvs.org/mutnomen/recs-DNA.html [den Dunnen et al., 2001; Ogino et al., 2007] . Primer sequences used in this study are listed in Supp. Table S1 .
Genotyping
Genomic DNA was extracted from peripheral white blood cells. HFE mutations c.845G>A (p.C282Y), c.187C>G (p.H63D) and c.193A>T (p.S65C), and five SNPs (rs2794720, rs2071303, rs1800758, rs1800708, rs1572982), were genotyped using PCR-RFLP for all patient and control individuals. PCR was carried out as previously described [Mura et al., 1999] , and restriction digests were performed according to the manufacturer's specifications (New England Biolabs, Ipswich, MA, USA) using 10 µL of PCR product and the appropriate restriction enzymes (Supp. Table S2 ). Digested products were resolved on a 2% agarose gel. At least one occurrence of each variant was confirmed by sequencing.
Sequencing
Chain terminator sequencing reactions were performed using the ABI BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Forster City, CA, USA) and analyzed on an ABI Prism 3130 Genetic Analyzer (Applied Biosystems, Forster City, CA, USA) according to the manufacturer's specifications.
Plasmid construction
HFE minigenes were cloned into the pcDNA3. ] polymorphisms) into pGEM-T easy. All inserts were then excised from pGEM-T using EagI, gel purified based on size, and ligated into the pcDNA3.1 NotI-digested vector. Orientation of the inserts and the constructed plasmids sequences were confirmed using automated DNA sequencing.
Analysis of spliced transcripts
In vitro transcription/splicing reactions were performed as described in Hicks et al. 2006 . Briefly, pcDNA3.1 plasmid minigene constructs were linearized with PvuI. One hundred nanograms of the digested products was incubated for 2 h at 30°C with 30% nuclear extract (HeLaScribe Nuclear extract in vitro transcription system, Promega, Madison, WI, USA); 0.4 mM each of rCTP, rUTP, and rATP, 16 µM rGTP; 1 mM ATP; 20 mM creatine phosphate; and 3 mM MgCl 2 in a 25-µL reaction. After the addition of 1 u DNase I, reactions were incubated for 15 min at 37°C. The reactions were stopped by the addition of 175 µL of 0.3 M Tris-HCl pH 7.4, 0.3 M sodium acetate, 0.5% SDS, 2 mM EDTA, and 0.3 µg/mL tRNA. The reaction products were extracted twice with phenol:chloroform:isoamyl alcohol (25:24:1) and precipitated overnight at -70°C with ethanol. RNAs pellets were resuspended in 20 µL of RNase-free water. Two-step RT-PCR reactions were performed by standard method using various sets of forward and reverse primers, and 5 µL of total RNA. The products of semi-quantitative PCR reactions (after 20-25 cycles, each consisting of 30 sec. at 95°C; 30 sec. at 57°C; and 1 min at 72°C), were analyzed on 2% agarose gel and gel images were digitally captured with a CCD camera and analyzed with the BioProfil Bio1D software imager program (Viber Lourmat, Marne-La-Vallée, France).
In silico DNA analysis
The haplotypes based on the five SNPs, as well as c.845G>A, c.187C>G and c.193A>T mutations, were derived from all the patients and controls using the PLINK software (http://pngu.mgh.harvard.edu/purcell/plink/) [Purcell et al., 2007] . The Human Splicing Finder 2.4 (http://www.umd.be/HSF/) sequence analysis algorithm was used to predict the effects of intervening sequence variations on splicing signals [Desmet et al., 2009] . This algorithm defines consensus values to 5' and 3' splice sites, maximizing the difference between wild type active sites and mutant inactive sites. A normalized range scale from 0 to 100 is used for auxiliary sequences, enhancers, and silencers. TFSEARCH (http://www.cbrc.jp/research/db/TFSEARCH.html) and MatInspector (http://www.genomatix.de/cgi-bin/eldorado/main.pl) programs were used to search for putative transcription factor binding sites.
Electrophoretic mobility shift assay
Sense and antisense single-stranded oligonucleotides from position g.4677 to position g.4710, including either the g.4694C or g.4694G variant (sense 5'-TTATGAAGGCTGTGGAAC/GGTGTTTCAGTAGGATC-3'), were labeled using the Biotin 3'-end DNA labeling kit (Pierce, Thermo Scientific, Essex, UK) according to the manufacturer's specifications. Gel shift assays were carried out using the Light Shift Chemiluminescent EMSA kit (Pierce, Thermo Scientific, Essex, UK). Briefly, 5 µg of nuclear extract, in 10 mM Tris pH7.5/50 mM KCl/1 mM DTT reaction buffer and 1 µg of poly(dI-dC) were pre-incubated for 10 min at room temperature. After the addition of labeled probe (20 fmol), the reaction mixture was incubated at room temperature for 30 min in a final volume of 20 µL. For competition experiments, 25-to 100-fold excess unlabeled oligonucleotides were incubated with the reaction mixture for 20 min before the addition of labeled probe. Then, the complexes were separated on a 5% polyacrylamide gel (29:1) in 0.5 x TBE, then chemiluminescence with streptavidin-horseradish peroxidase conjugate and substrate was used for detection of western blots. The signals were analyzed by densitometry on a GelDoc 2000 apparatus (Bio-Rad, Hercules, CA, USA).
Statistical analysis
The two-tailed Student's t-test was used to compare the mean age and mean value of serum iron parameters between groups of individuals. Deviation from Hardy-Weinberg equilibrium (HWE) of the genotyped SNPs (Fisher's exact test), haplotype and allele associations analysis with elevated serum iron parameters, (Fisher's exact test, Pearson's Chi square, and odds ratio), as well as linkage disequilibrium (D') calculations were performed using PLINK software (http://pngu.mgh.harvard.edu/purcell/plink/) [Purcell, et al., 2007] . A p-value less than 0.05 was considered statistically significant.
RESULTS
Mutation genotyping
In this study, patients, that all had elevated serum iron parameters and were treated by venesections, were divided into two groups. The first group, consisting of patients (n=195) either homozygous or compound heterozygous for the c.845G>A (p.C282Y), c.187C>G (p.H63D) or c.193A>T (p.S65C) mutations within the HFE coding sequence, was used to derived haplotypes. The alleles were distributed within this group as follows: c.845A/c.845A (n=128), c.187G/c.187G (n=34), c.845A/c.187G (n=19), c.845A/c.193T (n=10), c.187G/c.193T (n=4) (mean of iron removed 8.76 ± 5.68 g for c.845A/c.845A and 3.92 ± 1.65 g for the others). The second group consisted of patients (n=70) lacking mutations within the HFE coding region on at least one of their chromosomes (mean of iron removed 2.97 ± 1.17 g) and either c.845A heterozygotes (n=19), c.187G heterozygotes (n=15), or c.193T heterozygotes (n=2); thirty-four individuals from this group had no mutations within HFE coding region. For all patients lacking at least a mutation, the six HFE exons and intron-exons bundaries regions were sequenced to verify there were no additional mutations. The age, gender, and serum iron parameters of the patients (according to their genotype for the c.845G>A, c.187C>G and c.193A>T mutations) are listed in Table 1 . There were no significant differences observed for the age of diagnosis of iron overload trait between the genotypic groups, but c.845A/c.845A individuals were diagnosed at a younger age than the c.187G/wt, c.193T/wt and wt/wt individuals (p < 10 -3 , Student's t-test). Transferrin saturation and serum ferritin levels at diagnosis indicated that iron overload was milder in patients that were not homozygous for the c.845A mutation than in patients homozygous for the c.845A mutation (p < 0.05, Student's t-test). The mean age, with standard deviation (SD), age range, gender, transferrin saturation (TS) and serum ferritin (SF) values at diagnosis. P values were calculated with Student's t-test to compare age and iron parameters, respectively, between homozygotes and nonhomozygotes for the c.845A substitution.
Allele and haplotype frequencies analysis
SNPs and derived haplotypes were analyzed to gain more insight into a possible association between the specific alleles found within the patients (and therefore overrepresented in chromosomes of patients) and the iron status. Five previously reported SNPs located within the HFE locus [Beutler and West, 1997; Totaro et al., 1997] , one located within the promoter region and four located within intronic regions near splice boundaries, were screened by PCR-RFLP in patients and controls (Supp. Table S2 SNP and haplotypes from controls (n=42) and the group of patients with no mutations on at least one of their chromosomes (n=70) were analyzed. In this group of patients the c.845A carrier chromosomes, associated with [C; T; G; T; G] haplotype, tended to be at risk for iron overload trait (with frequency of 15.67% in patients versus 7.3% in healthy controls). Table 2 lists the SNP allele frequency distribution from the group of patients that lack mutations on at least one of their chromosomes and the control group, excluding the c.845A mutation-carrier chromosomes. The g.4694C (position: 5'UTR-467) allele is negatively associated with iron overload trait (Fisher's exact test, p=0.025; Chi square, 5.135 p=0.021; OR 0.5 [0.279-0.905]), and a total of 20 homozygous for g.4694G allele have been found in patients that do not carry any mutation within the coding sequence of HFE (n=34), whereas only 2 homozygous have been found in controls (n=42). The c.1007-47G allele had moderate negative association with iron overload trait (Fisher's exact test, p=0.058; Chi square, 3.864 p= 0.049; OR 0.56 [0.31-1]). The frequency of other SNP alleles was not significantly different in patients compared to controls. Interestingly, the c.187G and c.193T alleles were both in complete linkage disequilibrium with the c.1007-47A allele, but c.1007-47A was also found on some other non-mutant chromosomes. In addition, as previously noted the g.4694G (Table 3) . This association study suggests that the g.4694G, c.340+4C, and c.1007-47A alleles could play a role in the genetic etiology of iron overload in the population of being investigated.
Functional analysis of sequence variations
Examination of the human HFE promoter sequence using the TFSEARCH and MatInspector softwares shows that the g.4693 to g.4697 sequence, including nucleotide g.4694C (5'UTR-467C), encompasses a putative consensus hypoxia-response element (HRE), which is defined by the sequence [A/G]CGTG. HRE binds to the HIF-1α transcription factor, and the g.4694G nucleotide abolishes this binding site. To further characterize the g.4694C>G (5'UTR-467C>G) variation, located within the putative HRE, we tested for binding by the nuclear protein factor. Electrophoretic mobility shift assays (EMSA) of labeled-synthetic double-stranded oligonucleotides from both variants, after incubation with nuclear extract, provided evidence of the formation of protein-DNA complex with the sequence containing either the g.4694C or G variants (Fig. 1) . The interaction of the protein was abolished through competition experiments using an excess of an unlabeled homologous double-stranded oligonucleotide. Competition experiments using the g.4694G variant oligonucleotide sequence was twofold less efficient to abolish protein binding to the g.4694C variant oligonucleotide than the g.4694C unlabeled oligonucleotide. Complexes were then separated on 5% polyacrylamide gel (29:1) in 0.5 x TBE by electrophoresis. The mobility results showed the formation of protein-DNA complex for the g.4694C variant sequence after incubation with nuclear extract compared to incubation without nuclear extract. The complexes that formed with the g.4694C variant were abolished through competition experiments with the nuclear extracts that were preincubated with an excess of unlabeled homologous oligonucleotide. This demonstrates the specificity of the interaction between the nuclear proteins and the double-stranded oligonucleotide sequence. Quantitation of the binding efficiency by CCD camera scanning from 4 independent experiments obtained from competition experiments showed that the g.4694G variant oligonucleotide sequence was two-fold less efficient to abolish protein binding to the g.4694C variant oligonucleotide than the g.4694C unlabeled oligonucleotide.
To determine whether intronic sequence variations located within the splice site region (c.340+4T>C), or within a short distance of a splice site (c.892+48G>A, c.893-44T>C and c.1007-47G>A), could interfere with correct pre-mRNA splicing, sequence variations were submitted to Human Splicing Finder 2.4 (http://www.umd.be/HSF/) to predict any alteration in splicing in addition to splice factor binding sites that result in misregulated splicing. c.340+4T>C gives a ∆ Consensus Value of +9.71% exceeded the 7% for +4 position of the 5'splice site, a threshold value considered by the software to be indicative of a significant impact on splicing. RT-PCR products, analyzed for size, from HFE minigene expression plasmids harboring a combination of variants, were used as substrates for in vitro RNA synthesis and splicing in HeLa cell nuclear extracts. Fig. 1 ). There was a reduction of full-length spliced transcripts, and the amount of the unspliced IVS4 variant was increased 2-to 4-fold. On the other hand, the unspliced IVS5 transcript was unchanged in the haplotype carrying the c.1007-47A allele compared to the haplotype carrying the c.1007-47G allele.
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DISCUSSION
To gain more insight into HFE sequence variations, we analyzed a large number of patients (all from Brittany) affected with elevated serum iron parameters through use of internal HFE SNPs (g.4694G>C; c.340+4T>C; c.892+48G>A; c.893-44T>C; c.1007-47G>A) and derived haplotypes. The haplotype analysis confirmed that c.845G>A (p.C282Y) mutation-carrier chromosomes are in complete linkage disequilibrium with a unique [C; T; G; T; G] haplotype, which is quite common and accounts for about 20.6% of non-mutant chromosomes. The results of this study, in agreement with previous linkage disequilibrium data obtained by using external HFE gene microsatellites [Feder et al., 1996] , argues that the c.845G>A mutation occurred once on a progenitor haplotype, and spread throughout the Caucasian population.
HFE c.187C>G (p.H63D), and, to a lesser extent, c.193A>T (p.S65C) are variants associated with non-c.845A chromosomes from hemochromatosis patients. Both variants have a very low penetrance and mild expressivity for iron overload. Here, haplotype analysis revealed that the [C; C; G; T; A] and [G; C; G; T; A] haplotypes account for 79.8% and 20.2%, respectively, of c.187G-carrier chromosomes; these haplotypes only diverge for the g.4694G>C variation. This may suggest that the c.187G variant occurred once in the ancestral [C; C; G; T; A] haplotype, and that a subsequent divergence appeared at the g.4694C>G (5'UTR-467C>G) position. In this respect, g.4694C>G divergence could have arisen either by a mutational event or through recombination, but the lack of recombination observed in the HFE gene region, and the similar pattern of haplotypes defined with external microsatellites observed in the c.187G chromosomes, argues against the latter hypothesis [Feder et al., 1996] . Another assumption is that the c.187G mutation would have occurred twice on ancestral haplotypes, which account for 3.6% and 9.8%, respectively, of non-carrier chromosomes in controls. Interestingly, previous studies have shown that in populations of European descent, c.187G is associated with the [c. 340+4C; c.893-44T; c.1007-47A] haplotype. On the other hand, in Sri Lanka, where the allele frequency is about 10%, c.187G is associated with three haplotype backgrounds [c. 340+4T; c.893-44T; c.1007-47G] , [c.340+4T; c.893-44T; c.1007-47A] and [c.340+4C; c.893-44T; c.1007-47G] . These findings suggest that the c.187G mutation may have arisen more than once in Sri Lanka, independently from the mutation in Europe [Rochette et al., 1999] . Furthermore, despite its high prevalence in European populations, the low penetrance of the c.187G variant, together with the low prevalence of the disease among the Sri Lankan (Asian) population, casts doubt on the risk of developing the disease induced by this variant. This study showed that in Caucasian population the c.187G chromosomes, as well as the c.193T chromosomes, are in complete linkage disequilibrium with the c.1007-47A variant, whereas the g.4694G variant is in linkage disequilibrium with a subset of c.187G chromosomes that are increased in patients compared to controls. In addition, through comparisons with control subjects, the present study provides evidence of a significant association of the g.4694G variant with mild iron overload trait in non-c.845A, -c.187G or -c.193T patient chromosomes, as well as a weak association of the c.1007-47A variant. The results also show a risk of iron overload trait linked to the [g.4694G; c.340+4T; c.892+48G; c.893-44T; c.1007-47A] haplotype, and a protective role of the [g.4694C; c.340+4T; c.892+48G; c.893-44T; c.1007-47G] haplotype for non-mutant chromosomes differing by g.4694C>G and c.1007-47G>A variations, confirming the potential role of g.4694G and c.1007-47A in iron overload. g.4694C>G is located within a putative HRE binding site for the hypoxia-inducible transcription factor, HIF-1α, found in the HFE 5'-flanking region. The g.4694G allele was proved to reduce protein binding. It is worth noting that HIF-1α constitutes a link between the physiology of hypoxic response and the control of iron availability; in particular, its binding within the hepcidin sequence promoter is involved in the downregulation of hepcidin transcription [Peyssonnaux et al., 2007] , HIF-1 could thus be implicated in HFE transcriptional regulation. In addition, the c.1007-47A allele causes a reduction of IVS4 normal splicing compared to c.1007-47G. An analysis using the Human Splicing Finder software revealed that this change would abolish a IIE silencer motif and an hnRNPA site, and in doing so could have an impact on splicing. Therefore, the association of both g.4694C>G and c.1007G>A changes in sequence leading to a reduced response to HIF-1 transcription factor and/or to incorrect splicing of the transcript, would result in lower levels of intact mRNA and a reduction of functional HFE protein. The low penetrance of the c.187G mutation could thus be related to the increased risk for developing iron overload trait from a subset of c.187G chromosomes associated with the [g.4694G; c.340+4C; c.892+48G; c.893-44T; c.1007-47A] haplotype. The g.4694C>G variant and to a lesser extent c.1007G>A are significantly defined at risk for mild iron overload trait, consequently the screening of the g.4694C>G and c.1007G>A variations would bring additional refinement to the correlation between iron overload trait and HFE genotype. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Supp. Figure 1 . mRNA splicing assay. To carry out in vitro transcription/splicing studies a set of HFE minigenes that contained partial genomic sequences from exons 4 to 6 including various combinations of c.892+48G>A; c.893-44T>C; c.1007-47G>A within the pcDNA3.1 mammalian expression vector were constructed. Spliced mRNAs were revealed by RT-PCR using a set of primers (F7 R6 R7 R8) as indicated. The exons and introns (IVS) included in the minigenes are given the first and last nucleotide are numbered according to the NG_008720.1:g database and SNPs according to the NM_000410.3:c database. Forward (F) and reverse (R) primer locations and sequences used are listed in Supp. Table S1 . The expected fragment lengths (bp) are listed. Quantitation of RT-PCR products by CCD camera scanning from 3 independent experiments indicated a 4-fold increase in unspliced IVS4 mRNA from the IVS4+48G-IVS5-47A or IVS4+48A-IVS5-47A minigenes compared to the IVS4+48G-IVS5-47G minigene with F7 R6 and F7 R7 primers and a 2-fold increase in spliced IVS4 mRNA from the IVS4+48G-IVS5-47G minigene compared to the IVS4+48G-IVS5-47A or IVS4+48A-IVS5-47A minigenes with F7 R8 primers.
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